Former Drug CEO Not Expected To Answer House Panel's Questions
Martin Shkreli is to appear before a House panel Thursday for a hearing on drug prices. Shkreli's company purchased the life-saving drug Daraprim, and then raised the price by 5,000 percent.
Read more on NPR
No comments:
Post a Comment